世界の造血幹細胞（HSC）市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Hematopoietic Stem Cells (HSCs) Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z06865 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、造血幹細胞（HSC）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。造血幹細胞（HSC）の種類別市場規模（白血球、リンパ球、赤血球、血小板）、用途別市場規模（血液系疾患、自己免疫疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・造血幹細胞（HSC）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Kite Pharma Inc.、Thermo Fisher Scientific、PromoCell、CellGenix Technologie Transfer GmbH、Cesca Therapeutics Inc.、R&D Systems、Genlantis、Lonza Group Ltd.、TiGenix N.V.、ScienCell Research Laboratories、China Cord Blood Corporation、Vcanbio、Boyalife、Beike Biotechnology ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：白血球、リンパ球、赤血球、血小板 ・用途別分析2016年-2026年：血液系疾患、自己免疫疾患、その他 ・造血幹細胞（HSC）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・造血幹細胞（HSC）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・造血幹細胞（HSC）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・造血幹細胞（HSC）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・造血幹細胞（HSC）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Hematopoietic Stem Cells (HSCs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Hematopoietic Stem Cells (HSCs) size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Hematopoietic Stem Cells (HSCs) market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Hematopoietic Stem Cells (HSCs) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Leukocyte
Lymphocytes
Red Blood Cells
Platelets

Market segment by Application, can be divided into
Blood System Diseases
Autoimmune Diseases
Other

Market segment by players, this report covers
Kite Pharma Inc.
Thermo Fisher Scientific
PromoCell
CellGenix Technologie Transfer GmbH
Cesca Therapeutics Inc.
R&D Systems
Genlantis
Lonza Group Ltd.
TiGenix N.V.
ScienCell Research Laboratories
China Cord Blood Corporation
Vcanbio
Boyalife
Beike Biotechnology

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Hematopoietic Stem Cells (HSCs)
1.2 Classification of Hematopoietic Stem Cells (HSCs) by Type
1.2.1 Overview: Global Hematopoietic Stem Cells (HSCs) Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Type in 2020
1.2.3 Leukocyte
1.2.4 Lymphocytes
1.2.5 Red Blood Cells
1.2.6 Platelets
1.3 Global Hematopoietic Stem Cells (HSCs) Market by Application
1.3.1 Overview: Global Hematopoietic Stem Cells (HSCs) Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Blood System Diseases
1.3.3 Autoimmune Diseases
1.3.4 Other
1.4 Global Hematopoietic Stem Cells (HSCs) Market Size & Forecast
1.5 Global Hematopoietic Stem Cells (HSCs) Market Size and Forecast by Region
1.5.1 Global Hematopoietic Stem Cells (HSCs) Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Hematopoietic Stem Cells (HSCs) Market Size by Region, (2016-2021)
1.5.3 North America Hematopoietic Stem Cells (HSCs) Market Size and Prospect (2016-2026)
1.5.4 Europe Hematopoietic Stem Cells (HSCs) Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size and Prospect (2016-2026)
1.5.6 South America Hematopoietic Stem Cells (HSCs) Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Hematopoietic Stem Cells (HSCs) Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Hematopoietic Stem Cells (HSCs) Market Drivers
1.6.2 Hematopoietic Stem Cells (HSCs) Market Restraints
1.6.3 Hematopoietic Stem Cells (HSCs) Trends Analysis
2 Company Profiles
2.1 Kite Pharma Inc.
2.1.1 Kite Pharma Inc. Details
2.1.2 Kite Pharma Inc. Major Business
2.1.3 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Product and Solutions
2.1.4 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Kite Pharma Inc. Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Product and Solutions
2.2.4 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 PromoCell
2.3.1 PromoCell Details
2.3.2 PromoCell Major Business
2.3.3 PromoCell Hematopoietic Stem Cells (HSCs) Product and Solutions
2.3.4 PromoCell Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 PromoCell Recent Developments and Future Plans
2.4 CellGenix Technologie Transfer GmbH
2.4.1 CellGenix Technologie Transfer GmbH Details
2.4.2 CellGenix Technologie Transfer GmbH Major Business
2.4.3 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Product and Solutions
2.4.4 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 CellGenix Technologie Transfer GmbH Recent Developments and Future Plans
2.5 Cesca Therapeutics Inc.
2.5.1 Cesca Therapeutics Inc. Details
2.5.2 Cesca Therapeutics Inc. Major Business
2.5.3 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Product and Solutions
2.5.4 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Cesca Therapeutics Inc. Recent Developments and Future Plans
2.6 R&D Systems
2.6.1 R&D Systems Details
2.6.2 R&D Systems Major Business
2.6.3 R&D Systems Hematopoietic Stem Cells (HSCs) Product and Solutions
2.6.4 R&D Systems Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 R&D Systems Recent Developments and Future Plans
2.7 Genlantis
2.7.1 Genlantis Details
2.7.2 Genlantis Major Business
2.7.3 Genlantis Hematopoietic Stem Cells (HSCs) Product and Solutions
2.7.4 Genlantis Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Genlantis Recent Developments and Future Plans
2.8 Lonza Group Ltd.
2.8.1 Lonza Group Ltd. Details
2.8.2 Lonza Group Ltd. Major Business
2.8.3 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Product and Solutions
2.8.4 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Lonza Group Ltd. Recent Developments and Future Plans
2.9 TiGenix N.V.
2.9.1 TiGenix N.V. Details
2.9.2 TiGenix N.V. Major Business
2.9.3 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Product and Solutions
2.9.4 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 TiGenix N.V. Recent Developments and Future Plans
2.10 ScienCell Research Laboratories
2.10.1 ScienCell Research Laboratories Details
2.10.2 ScienCell Research Laboratories Major Business
2.10.3 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Product and Solutions
2.10.4 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 ScienCell Research Laboratories Recent Developments and Future Plans
2.11 China Cord Blood Corporation
2.11.1 China Cord Blood Corporation Details
2.11.2 China Cord Blood Corporation Major Business
2.11.3 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Product and Solutions
2.11.4 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 China Cord Blood Corporation Recent Developments and Future Plans
2.12 Vcanbio
2.12.1 Vcanbio Details
2.12.2 Vcanbio Major Business
2.12.3 Vcanbio Hematopoietic Stem Cells (HSCs) Product and Solutions
2.12.4 Vcanbio Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Vcanbio Recent Developments and Future Plans
2.13 Boyalife
2.13.1 Boyalife Details
2.13.2 Boyalife Major Business
2.13.3 Boyalife Hematopoietic Stem Cells (HSCs) Product and Solutions
2.13.4 Boyalife Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Boyalife Recent Developments and Future Plans
2.14 Beike Biotechnology
2.14.1 Beike Biotechnology Details
2.14.2 Beike Biotechnology Major Business
2.14.3 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Product and Solutions
2.14.4 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Beike Biotechnology Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Hematopoietic Stem Cells (HSCs) Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Hematopoietic Stem Cells (HSCs) Players Market Share
3.2.2 Top 10 Hematopoietic Stem Cells (HSCs) Players Market Share
3.2.3 Market Competition Trend
3.3 Hematopoietic Stem Cells (HSCs) Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Hematopoietic Stem Cells (HSCs) Revenue and Market Share by Type (2016-2021)
4.2 Global Hematopoietic Stem Cells (HSCs) Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Application (2016-2021)
5.2 Hematopoietic Stem Cells (HSCs) Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Hematopoietic Stem Cells (HSCs) Revenue by Type (2016-2026)
6.2 North America Hematopoietic Stem Cells (HSCs) Revenue by Application (2016-2026)
6.3 North America Hematopoietic Stem Cells (HSCs) Market Size by Country
6.3.1 North America Hematopoietic Stem Cells (HSCs) Revenue by Country (2016-2026)
6.3.2 United States Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2016-2026)
6.3.3 Canada Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2016-2026)
6.3.4 Mexico Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Hematopoietic Stem Cells (HSCs) Revenue by Type (2016-2026)
7.2 Europe Hematopoietic Stem Cells (HSCs) Revenue by Application (2016-2026)
7.3 Europe Hematopoietic Stem Cells (HSCs) Market Size by Country
7.3.1 Europe Hematopoietic Stem Cells (HSCs) Revenue by Country (2016-2026)
7.3.2 Germany Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2016-2026)
7.3.3 France Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2016-2026)
7.3.5 Russia Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2016-2026)
7.3.6 Italy Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue by Type (2016-2026)
8.2 Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue by Application (2016-2026)
8.3 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Region
8.3.1 Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue by Region (2016-2026)
8.3.2 China Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2016-2026)
8.3.3 Japan Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2016-2026)
8.3.4 South Korea Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2016-2026)
8.3.5 India Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2016-2026)
8.3.7 Australia Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Hematopoietic Stem Cells (HSCs) Revenue by Type (2016-2026)
9.2 South America Hematopoietic Stem Cells (HSCs) Revenue by Application (2016-2026)
9.3 South America Hematopoietic Stem Cells (HSCs) Market Size by Country
9.3.1 South America Hematopoietic Stem Cells (HSCs) Revenue by Country (2016-2026)
9.3.2 Brazil Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2016-2026)
9.3.3 Argentina Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue by Type (2016-2026)
10.2 Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue by Application (2016-2026)
10.3 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Country
10.3.1 Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue by Country (2016-2026)
10.3.2 Turkey Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2016-2026)
10.3.4 UAE Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Hematopoietic Stem Cells (HSCs) Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Hematopoietic Stem Cells (HSCs) Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Hematopoietic Stem Cells (HSCs) Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Hematopoietic Stem Cells (HSCs) Revenue (USD Million) by Region (2016-2021)
Table 5. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Region (2021-2026)
Table 6. Kite Pharma Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Kite Pharma Inc. Major Business
Table 8. Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 9. Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Major Business
Table 12. Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 13. Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. PromoCell Corporate Information, Head Office, and Major Competitors
Table 15. PromoCell Major Business
Table 16. PromoCell Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 17. PromoCell Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. CellGenix Technologie Transfer GmbH Corporate Information, Head Office, and Major Competitors
Table 19. CellGenix Technologie Transfer GmbH Major Business
Table 20. CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 21. CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Cesca Therapeutics Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Cesca Therapeutics Inc. Major Business
Table 24. Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 25. Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. R&D Systems Corporate Information, Head Office, and Major Competitors
Table 27. R&D Systems Major Business
Table 28. R&D Systems Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 29. R&D Systems Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Genlantis Corporate Information, Head Office, and Major Competitors
Table 31. Genlantis Major Business
Table 32. Genlantis Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 33. Genlantis Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Lonza Group Ltd. Corporate Information, Head Office, and Major Competitors
Table 35. Lonza Group Ltd. Major Business
Table 36. Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 37. Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. TiGenix N.V. Corporate Information, Head Office, and Major Competitors
Table 39. TiGenix N.V. Major Business
Table 40. TiGenix N.V. Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 41. TiGenix N.V. Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. ScienCell Research Laboratories Corporate Information, Head Office, and Major Competitors
Table 43. ScienCell Research Laboratories Major Business
Table 44. ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 45. ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. China Cord Blood Corporation Corporate Information, Head Office, and Major Competitors
Table 47. China Cord Blood Corporation Major Business
Table 48. China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 49. China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Vcanbio Corporate Information, Head Office, and Major Competitors
Table 51. Vcanbio Major Business
Table 52. Vcanbio Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 53. Vcanbio Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Boyalife Corporate Information, Head Office, and Major Competitors
Table 55. Boyalife Major Business
Table 56. Boyalife Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 57. Boyalife Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Beike Biotechnology Corporate Information, Head Office, and Major Competitors
Table 59. Beike Biotechnology Major Business
Table 60. Beike Biotechnology Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 61. Beike Biotechnology Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Global Hematopoietic Stem Cells (HSCs) Revenue (USD Million) by Players (2019-2021)
Table 63. Global Hematopoietic Stem Cells (HSCs) Revenue Share by Players (2019-2021)
Table 64. Breakdown of Hematopoietic Stem Cells (HSCs) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Hematopoietic Stem Cells (HSCs) Players Head Office, Products and Services Provided
Table 66. Hematopoietic Stem Cells (HSCs) Mergers & Acquisitions in the Past Five Years
Table 67. Hematopoietic Stem Cells (HSCs) New Entrants and Expansion Plans
Table 68. Global Hematopoietic Stem Cells (HSCs) Revenue (USD Million) by Type (2016-2021)
Table 69. Global Hematopoietic Stem Cells (HSCs) Revenue Share by Type (2016-2021)
Table 70. Global Hematopoietic Stem Cells (HSCs) Revenue Forecast by Type (2021-2026)
Table 71. Global Hematopoietic Stem Cells (HSCs) Revenue by Application (2016-2021)
Table 72. Global Hematopoietic Stem Cells (HSCs) Revenue Forecast by Application (2021-2026)
Table 73. North America Hematopoietic Stem Cells (HSCs) Revenue by Type (2016-2021) & (USD Million)
Table 74. North America Hematopoietic Stem Cells (HSCs) Revenue by Type (2021-2026) & (USD Million)
Table 75. North America Hematopoietic Stem Cells (HSCs) Revenue by Application (2016-2021) & (USD Million)
Table 76. North America Hematopoietic Stem Cells (HSCs) Revenue by Application (2021-2026) & (USD Million)
Table 77. North America Hematopoietic Stem Cells (HSCs) Revenue by Country (2016-2021) & (USD Million)
Table 78. North America Hematopoietic Stem Cells (HSCs) Revenue by Country (2021-2026) & (USD Million)
Table 79. Europe Hematopoietic Stem Cells (HSCs) Revenue by Type (2016-2021) & (USD Million)
Table 80. Europe Hematopoietic Stem Cells (HSCs) Revenue by Type (2021-2026) & (USD Million)
Table 81. Europe Hematopoietic Stem Cells (HSCs) Revenue by Application (2016-2021) & (USD Million)
Table 82. Europe Hematopoietic Stem Cells (HSCs) Revenue by Application (2021-2026) & (USD Million)
Table 83. Europe Hematopoietic Stem Cells (HSCs) Revenue by Country (2016-2021) & (USD Million)
Table 84. Europe Hematopoietic Stem Cells (HSCs) Revenue by Country (2021-2026) & (USD Million)
Table 85. Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue by Type (2016-2021) & (USD Million)
Table 86. Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue by Type (2021-2026) & (USD Million)
Table 87. Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue by Application (2016-2021) & (USD Million)
Table 88. Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue by Application (2021-2026) & (USD Million)
Table 89. Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue by Region (2016-2021) & (USD Million)
Table 90. Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue by Region (2021-2026) & (USD Million)
Table 91. South America Hematopoietic Stem Cells (HSCs) Revenue by Type (2016-2021) & (USD Million)
Table 92. South America Hematopoietic Stem Cells (HSCs) Revenue by Type (2021-2026) & (USD Million)
Table 93. South America Hematopoietic Stem Cells (HSCs) Revenue by Application (2016-2021) & (USD Million)
Table 94. South America Hematopoietic Stem Cells (HSCs) Revenue by Application (2021-2026) & (USD Million)
Table 95. South America Hematopoietic Stem Cells (HSCs) Revenue by Country (2016-2021) & (USD Million)
Table 96. South America Hematopoietic Stem Cells (HSCs) Revenue by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue by Type (2016-2021) & (USD Million)
Table 98. Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue by Type (2021-2026) & (USD Million)
Table 99. Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue by Application (2016-2021) & (USD Million)
Table 100. Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue by Application (2021-2026) & (USD Million)
Table 101. Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue by Country (2016-2021) & (USD Million)
Table 102. Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Hematopoietic Stem Cells (HSCs) Picture
Figure 2. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Type in 2020
Figure 3. Leukocyte
Figure 4. Lymphocytes
Figure 5. Red Blood Cells
Figure 6. Platelets
Figure 7. Hematopoietic Stem Cells (HSCs) Revenue Market Share by Application in 2020
Figure 8. Blood System Diseases Picture
Figure 9. Autoimmune Diseases Picture
Figure 10. Other Picture
Figure 11. Global Hematopoietic Stem Cells (HSCs) Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Hematopoietic Stem Cells (HSCs) Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Region (2016-2026)
Figure 14. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Region in 2020
Figure 15. North America Hematopoietic Stem Cells (HSCs) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Hematopoietic Stem Cells (HSCs) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Hematopoietic Stem Cells (HSCs) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Hematopoietic Stem Cells (HSCs) Market Drivers
Figure 20. Hematopoietic Stem Cells (HSCs) Market Restraints
Figure 21. Hematopoietic Stem Cells (HSCs) Market Trends
Figure 22. Kite Pharma Inc. Recent Developments and Future Plans
Figure 23. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 24. PromoCell Recent Developments and Future Plans
Figure 25. CellGenix Technologie Transfer GmbH Recent Developments and Future Plans
Figure 26. Cesca Therapeutics Inc. Recent Developments and Future Plans
Figure 27. R&D Systems Recent Developments and Future Plans
Figure 28. Genlantis Recent Developments and Future Plans
Figure 29. Lonza Group Ltd. Recent Developments and Future Plans
Figure 30. TiGenix N.V. Recent Developments and Future Plans
Figure 31. ScienCell Research Laboratories Recent Developments and Future Plans
Figure 32. China Cord Blood Corporation Recent Developments and Future Plans
Figure 33. Vcanbio Recent Developments and Future Plans
Figure 34. Boyalife Recent Developments and Future Plans
Figure 35. Beike Biotechnology Recent Developments and Future Plans
Figure 37. Global Hematopoietic Stem Cells (HSCs) Revenue Share by Players in 2020
Figure 38. Hematopoietic Stem Cells (HSCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 39. Global Top 3 Players Hematopoietic Stem Cells (HSCs) Revenue Market Share in 2020
Figure 40. Global Top 10 Players Hematopoietic Stem Cells (HSCs) Revenue Market Share in 2020
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 42. Global Hematopoietic Stem Cells (HSCs) Revenue Share by Type in 2020
Figure 43. Global Hematopoietic Stem Cells (HSCs) Market Share Forecast by Type (2021-2026)
Figure 44. Global Hematopoietic Stem Cells (HSCs) Revenue Share by Application in 2020
Figure 45. Global Hematopoietic Stem Cells (HSCs) Market Share Forecast by Application (2021-2026)
Figure 46. North America Hematopoietic Stem Cells (HSCs) Sales Market Share by Type (2016-2026)
Figure 47. North America Hematopoietic Stem Cells (HSCs) Sales Market Share by Application (2016-2026)
Figure 48. North America Hematopoietic Stem Cells (HSCs) Revenue Market Share by Country (2016-2026)
Figure 49. United States Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Canada Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Mexico Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Europe Hematopoietic Stem Cells (HSCs) Sales Market Share by Type (2016-2026)
Figure 53. Europe Hematopoietic Stem Cells (HSCs) Sales Market Share by Application (2016-2026)
Figure 54. Europe Hematopoietic Stem Cells (HSCs) Revenue Market Share by Country (2016-2026)
Figure 55. Germany Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific Hematopoietic Stem Cells (HSCs) Sales Market Share by Type (2016-2026)
Figure 61. Asia-Pacific Hematopoietic Stem Cells (HSCs) Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue Market Share by Region (2016-2026)
Figure 63. China Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South Korea Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Hematopoietic Stem Cells (HSCs) Sales Market Share by Type (2016-2026)
Figure 70. South America Hematopoietic Stem Cells (HSCs) Sales Market Share by Application (2016-2026)
Figure 71. South America Hematopoietic Stem Cells (HSCs) Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East and Africa Hematopoietic Stem Cells (HSCs) Sales Market Share by Type (2016-2026)
Figure 75. Middle East and Africa Hematopoietic Stem Cells (HSCs) Sales Market Share by Application (2016-2026)
Figure 76. Middle East and Africa Hematopoietic Stem Cells (HSCs) Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. UAE Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source

---